We conducted a survey of #BioPharma professionals to learn more about their usage and experiences with scientific lab data platforms.
🌟Enhancing data quality and integrity was the top lab data management goal for 32% of respondents.
Learn more: https://t.co/f43yG4wbxG
We’re proud to be sponsoring #VentureRoadUK, taking place 7-11 June across London, Cambridge and Oxford.
The IDBS team will be in attendance, sharing insights into how life sciences organizations can scale AI initiatives with confidence.
Learn more: https://t.co/L6Z8OPowXp
You’ve done the hard work but your data is in chaos.
IDBS Polar Inventory brings experiment data together into one single connected record, ensuring complete, transparent and audit-ready traceability from start to finish: https://t.co/N9cnOtadMX
#UpstreamDevelopment
With real examples and live demonstrations, our on-demand webinar shows how CMC teams can move beyond storing data to telling the full, defensible story of the process — what happened, when, why, and under which conditions.
👉 Watch now: https://t.co/dcN5N9vq73
#DigitalCMC
How easily can your team answer: “Where does this product’s shelf life stand?”
The Stability Insight App in IDBS Polar helps teams move from assembling data to making informed decisions, with connected insight across studies: https://t.co/Zw8HdnP1m5
#StabilityStudies
In #BioPharma, tight timelines, rising costs and increasing regulatory pressure mean cloud migration is no longer just an IT decision—it’s an operating‑model decision.
👉Read our blog to learn why cloud migration is a cornerstone of business agility: https://t.co/u2WItou7hG
#AI is dominating the conversation in life sciences right now, but our #i3 panel reminded us to look beyond the hype.
AI success in #lifesciences will depend less on the technology, and more on the strength of data foundations and the ability to drive real organizational change.
🧠At the Pistoia Alliance Spring Conference, a live poll showed that while many organizations have #AI platforms, only 4% can point to tangible R&D benefits, and 69% lack clear metrics to measure AI impact.
Discover how ready your data is for AI: https://t.co/w2WhB3p0Gv
Coming to you live from Bio-IT World Boston! Great to see so many conversations happening at the IDBS booth (511).
Earlier today, Scott Weiss shared how AI-ready scientific data starts with a context-first architecture.
🔗 https://t.co/uPghV97Lon
#BioITWorld
🧬This week at Bio‑IT World Boston, see how #AI in IDBS Polar is being built to deliver on its context‑first, AI‑ready scientific data.
📍Visit us at Booth #511 to see Polar in action and learn about our early access program.
Learn more:
https://t.co/BjIFpjWCXs
#BioITWorld
✅It’s a wrap: IDBS’ i3 customer-event in Boston, MA, has just concluded. Attendees gained an insight into how to leverage our scientific data management and lab informatics technology to deliver actionable insights and accelerate time to market.
#i32026
We’re looking forward to attending the SCIEX Discovery Continuum Seminar today.
It's a great opportunity to hear from SCIEX and industry experts on the latest advances in mass spectrometry and capillary electrophoresis.
Register: https://t.co/M1Uvoeb5y4
#DrugDiscovery
Bayer Crop Science delivered the closing customer presentation at i3 with an insightful talk from Jennifer Green and Yelena Hines on the advantages of migrating from on-prem IDBS E-WorkBook to SaaS IDBS Polar.
Explore IDBS Polar: https://t.co/nqYmsgWCTg
#i32026#IDBSPolar
⏱️Novartis builds a discovery bioanalysis LIMS application for data workflow automation.
At i3, Daniel Wall outlined how the team used Bioanalysis SmartBook built on IDBS E-WorkBook spreadsheets to streamline lab workflows.
Get in touch: https://t.co/EH34YkhSi3
#i32026
🪄Novartis showcased an exciting digital transformation at i3 2026, moving beyond spreadsheets to a truly end-to-end GxP platform for regulated ligand binding assay bioanalysis, with IDBS Polar.
Learn more in the GxP hub: https://t.co/E6dRtjHDlg
#i32026#Bioanalysis
🤔How did Boehringer Ingelheim save approx 3 hours per experiment?*
Brad Feilmeier revealed all in his i3 talk ‘From pain points to productivity: Transforming research workflows with IDBS.’
Learn more: https://t.co/IIl501tqQO
#i32026
*Data on file at Boehringer Ingelheim
Eisai cuts both planning and assay execution time by 75%.*
Shawn Fernando presented at i3 how Eisai built an inventory-driven architecture that makes materials, samples and equipment the backbone of the ELN
Get in touch: https://t.co/6ALVuWuk5g
#i32026
*Data on file at Eisai
Chugai Pharmaceutical opened the customer presentations at i3 with a session on bridging the gap between conceptual data strategy and practical, daily lab operations.
Discover how IDBS solutions can solve key bioprocessing challenges: https://t.co/bX8IG7fo0b
#i32026
How are companies distinguishing between "moonshot" automation and validated digital tools that can be deployed today?
That's the question Pharma's Almanac put to a panel of industry experts – read Marc Smith's take here: https://t.co/H9f0bh2DzX
#DataManagement#DigitalTools
Stability execution doesn’t need more reminders or better spreadsheets. It needs ownership of alignment: from protocol intent through every scheduled pull.
Learn how teams are addressing the root cause, not just the symptoms:
https://t.co/x8orGjxTeS
#StabilityStudies